Brazil Cannabis Laws
Your complete guide to cannabis legality, possession rules, medical access, and what tourists need to know before visiting Brazil.
- Legal Status: Medical CBD products legal; recreational cannabis illegal but personal use decriminalized (no jail time)
- Possession: No fixed gram limit — personal use vs. trafficking determined by judicial discretion
- Cultivation: Illegal, though ANVISA has authorized some research and medical cultivation
- Sales Model: No licensed recreational sales; CBD pharmacy products available with prescription
- Medical Program: ANVISA-regulated since 2015; CBD products available at pharmacies since 2019; full-flower medical cannabis expanding
- Supreme Court Case: Historic 2024 STF ruling decriminalizing personal possession still being implemented
- Tourist Risk: High — no legal purchase options, police discretion wide, deportation possible
Legal Status of Cannabis in Brazil
Brazil's relationship with cannabis is one of the most complex and evolving in Latin America. The country sits at an intersection of strict anti-drug legislation, an expanding medical cannabis framework, and a growing cultural movement pushing for broader reform. Understanding where Brazil stands legally in requires tracing a winding legislative and judicial history spanning nearly two decades.
The foundational law governing drug use in Brazil is Law 11.343/2006, commonly known as the Lei de Drogas (Drug Law). This legislation made a significant departure from its predecessor by eliminating criminal penalties — specifically imprisonment — for personal drug possession and use. However, it deliberately avoided setting a fixed possession threshold to define the boundary between user and trafficker, leaving that determination to judges and police officers based on circumstantial evidence including the quantity found, how it was packaged, the location, and the individual's background.
In practice, this created a deeply unequal system. Wealthier, white Brazilians caught with cannabis were far more likely to be treated as personal users, while poorer, Black Brazilians from favelas faced a significantly higher risk of being charged as traffickers — even for equivalent or smaller quantities. This disparity became a central issue in Brazil's ongoing drug policy debate and contributed to pressure for reform.
A landmark moment came in 2024 when Brazil's Supreme Federal Tribunal (STF) ruled, in a 6-5 decision, that the criminalization of personal cannabis possession was unconstitutional. This historic ruling effectively decriminalized possession for personal use at the constitutional level, though the Brazilian Congress — which holds legislative power — moved swiftly to push back, passing a constitutional amendment that explicitly prohibits the decriminalization of drugs. As of early, the legal tension between the STF ruling and congressional action remains unresolved and is subject to ongoing judicial interpretation.
Meanwhile, on the medical front, Brazil's health regulatory agency ANVISA (Agência Nacional de Vigilância Sanitária) first authorized cannabis-based medicines in 2015. In 2019, regulations were expanded significantly to allow the import and commercialization of CBD products with less than 0.2% THC at pharmacies, with a valid prescription. By 2021, domestic production of medical cannabis was authorized under strict licensing requirements. Brazil's medical cannabis industry has grown rapidly, with dozens of companies now licensed to cultivate and manufacture cannabis-derived products for medical use.
Recreational cannabis, however, remains firmly illegal under federal law, and Brazil has no immediate legislative pathway to full legalization comparable to countries like Uruguay (its neighbor that became the world's first country to fully legalize recreational cannabis in 2013) or the growing list of nations that have moved toward legalization.
"Brazil's cannabis policy sits at a crossroads — a medical sector expanding rapidly, a Supreme Court ruling challenging the constitutional basis of prohibition, and a Congress determined to maintain criminalization. The result is a system where the law depends heavily on who you are and where you are."
Possession & Penalties in Brazil
Brazil's penalty structure for cannabis offenses divides sharply between personal use and trafficking, with a dangerously vague middle ground that leaves individuals vulnerable to harsh judicial discretion. Here is a detailed breakdown of what the law prescribes — and what happens in practice.
The most critical thing to understand is that while personal users cannot be imprisoned under the 2006 law, the determination of whether someone is a "user" or "trafficker" is made by authorities on the scene and confirmed by judges. There is no minimum possession quantity that guarantees you will be treated as a personal user. Learn more about how drug testing and evidence affects these cases in our drug testing guide and our cannabis explainers.
| Offense | Legal Classification | Criminal Penalty | Other Consequences |
|---|---|---|---|
| Personal Use / Possession (small amount) | Administrative offense (Law 11.343/2006, Art. 28) | No imprisonment; no criminal record created | Community service, educational programs, fines; substance confiscated |
| Trafficking / Distribution | Criminal offense (Law 11.343/2006, Art. 33) | 5 to 15 years imprisonment + fines | Criminal record; asset forfeiture; significant social consequences |
| Cultivation (personal supply claimed) | Typically treated as trafficking unless clearly personal | 5 to 15 years (same as trafficking) | Plant destruction; property search; criminal record |
| Large-Scale Trafficking / Organized Crime | Aggravated trafficking offense | Up to 20+ years (with aggravating factors) | Organized crime statutes may apply; enhanced sentencing |
| Driving Under Influence of Cannabis | Traffic Code violation | Fines, license suspension; potential criminal charges | Vehicle impoundment; DUI record |
| Medical Cannabis (ANVISA-authorized) | Legal with valid prescription and documentation | None | Must carry prescription and product documentation |
It is worth noting that Brazil's prison system is severely overcrowded, and a significant proportion of inmates are incarcerated on drug trafficking charges. The lack of a clear legal threshold has fueled mass incarceration, particularly of young, poor, and Black Brazilians, a crisis that has galvanized reform advocates across the country.
For Tourists: What Visitors Need to Know
If you are visiting Brazil as a tourist and considering cannabis, you must understand clearly: there is no legal way for tourists to purchase or consume recreational cannabis in Brazil. Unlike destinations such as the Netherlands or certain US states, Brazil has no licensed dispensaries, cannabis cafes, or social clubs where visitors can legally access cannabis.
Here is what tourists should know before visiting Brazil:
- No legal purchase: There are no dispensaries, cannabis cafes, or licensed recreational retailers in Brazil.
- Personal possession risk: Even small amounts can result in police stops, confiscation, and hours at a police station — not an experience you want on vacation.
- Tourist vulnerability: Foreign nationals face additional risks, including deportation, visa cancellations, and entry bans for future visits.
- Police discretion is wide: Officers can and do treat similar situations very differently depending on neighborhood, appearance, and their own judgment.
- Favela tourism: Some tourist agencies offer favela tours; cannabis may be visible and accessible in these areas, but these are illegal black markets with significant personal safety risks beyond just legal consequences.
- Airport/border: Brazilian airports and border crossings are strictly enforced. Bringing cannabis into or out of Brazil is considered trafficking and carries severe criminal penalties.
- CBD products: Internationally purchased CBD products with less than 0.2% THC may be carried for personal use, but documentation is strongly recommended. Check our explainers section for more on CBD legality abroad.
Popular tourist destinations like Rio de Janeiro and São Paulo have active underground cannabis markets, particularly in beach communities, music venues, and nightlife districts. While enforcement can appear lax in some tourist-heavy areas, the legal risk is always present and the consequences for foreigners can be severe. Review our complete cannabis travel guide before planning any trip abroad where cannabis laws differ from your home state or country.
Medical Cannabis in Brazil
Brazil has one of Latin America's most developed medical cannabis frameworks, having moved progressively from a complete ban to a regulated medical market over roughly a decade. The journey began in earnest in 2014 when the family of Anny Fischer — a young girl with severe epilepsy — successfully lobbied ANVISA to allow the import of CBD oil for her treatment. This case catalyzed broader regulatory change.
In 2015, ANVISA formally authorized cannabis-based medicines for medical use. In 2019, regulations were updated to allow CBD-predominant products (less than 0.2% THC) to be sold directly at pharmacies with a prescription. By 2021, domestic cultivation and manufacturing of medical cannabis products were authorized under a licensing system, creating a fledgling but growing Brazilian cannabis industry.
| Medical Program Element | Details |
|---|---|
| Regulatory Body | ANVISA (Agência Nacional de Vigilância Sanitária) |
| First Authorization | 2015 — cannabis-based medicines approved |
| Pharmacy Access | Since 2019 — CBD products (<0.2% THC) available with prescription |
| Domestic Production Authorized | 2021 — licensed cultivation and manufacturing permitted |
| Qualifying Conditions | Epilepsy, chronic pain, cancer, anxiety disorders, Parkinson's, MS, and others at physician discretion |
| Prescription Requirement | Brazilian physician prescription required; valid ANVISA registration |
| THC-Containing Products | Available through import authorization; increasingly available domestically |
| Access for Foreigners | Extremely limited; requires Brazilian prescription and residency proof |
| Cannabis Associations | Non-profit cannabis associations operate in legal grey area, primarily focused on medical patients |
Qualifying conditions for medical cannabis in Brazil include epilepsy (particularly treatment-resistant childhood epilepsy), chronic pain, nausea associated with chemotherapy, multiple sclerosis spasticity, Parkinson's disease, anxiety disorders, and other conditions at the prescribing physician's discretion. Brazil's medical framework is notably flexible in terms of qualifying conditions compared to some other nations, as the ANVISA regulations do not strictly define an exclusive list.